

Research Studies
- Inflammatory Bowel Disease () Database Registry sponsored by the National PediIBD Consortium
- The Pediatric Network for Research and Improvement (Pedi IBDNet)
- The Role of Infectious Agents in Pediatric (CD) sponsored by the National Institutes of Health (NIH)
- A Multi-Center, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetcs of the Human Anti-TNF Monoclonocal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe sponsored by Abbott Pharmaceuticals
- A Prospective Randomized Double-Blind Study of PASER (a 4-ASA) in the Management of Patients Experiencing an Acute Flare of sponsored by Jacobus Pharmaceuticals
- A Phase 3, Randomized, Open-label, Parallel-group, Multicenter Trial to Evaluate the Safety and Efficacy of Infliximab (Remicade) in Pediatric Subjects with Moderately to Active sponsored by Centocor Pharmaceuticals
- The NASPGHAN, Pediatric System for the Clinical Outcomes Research Initiative (PEDS-CORI)
- Gastroesophageal Reflux Disease () and Dental Erosions sponsored by TAP Pharmaceuticals
- Gender Differences in Growth in Pediatric Patients with Crohn's Disease sponsored by the CDHNF, CCFA, and NIH.
For more information, contact Dr. Neera Gupta or
Dr. Mel Heyman 415-476-5892 or Ann Clark at 415-476-2170
We often have new studies to offer to kids with IBD. For more information, please contact
Liz Garnett at (415) 514-4BID (4423) or via email

- Maternal nutrition knowledge
- UC_MEXUS
Risk Factors for Pediatric Overweight Including Migration and Acculturation:
Two Case Control Studies in the Tijuana and San Francisco Public Schools
For more information, please contact
Janet Wojcicki at (415) 476-2380 or via email

- A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study of the
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents
(Age 2 to < 18) with Chronic
sponsored by Gilead Pharmaceuticals
- Pegylated Interferon +/- Ribavirin for Children with
(PEDS-C) sponsored by the National Institutes of Health (NIH) / National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- SPLIT--Studies of Pediatric ,
(is a multi-center, prospective study to collect scientific data in
pediatric liver transplantation) sponsored by the NIH
- Non-Alcoholic Study
(NASH) sponsored by the National Institutes of Health (NIH)
- Pediatric Acute Study
(ALF) sponsored by the National Institutes of Health (NIH)
- Pediatric Non Acetylcysteine (NAC) for Acute Study (NAC for ALF) sponsored by the National Institutes
of Health (NIH)
- Mycophenolate mofetil for Pediatric sponsored by Roche Pharmaceuticals
- + Children
sponsored by the National Institutes of Health (NIH) National Institute
Allergy and Infectious Disease
- A Prospective Database of Infants with
conducted by the Biliary Atresia Research Consortium, sponsored by the
National Institute of Diabetes, Digestive, and Kidney Diseases of the
National Institutes of Health (NIH)
- Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients with the Department of Health and Human Service
For more information, please contact
Danusia Filipowski at (415) 476-1756 or via email or
Whitney Lieb at (415) 476-1539 or via email

|